PannTheraPi Advances Epilepsy Treatment with Upcoming Phase IIa Clinical Trial
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…